Iconovo
1.7
SEK
-1.16 %
Less than 1K followers
ICO
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
Iconovo is a medical technology company. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and carbon monoxide, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and is headquartered in Lund.
Read moreMarket cap
90.2M SEK
Turnover
176.95K SEK
Revenue
2.93M
EBIT %
-1,402.05 %
P/E
-
Dividend yield-%
-
Financial calendar
14/7
2025
Interim report Q2'25
24/10
2025
Interim report Q3'25
All
Press releases
3rd party
ShowingAll content types
Iconovo’s rights issue is registered – conversion of BTA into shares
Iconovos utveckling av intranasal GLP-1 för en enklare behandling av fetma gör betydande framsteg
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools